Robert, who is the Principal at the communications and strategy consulting firm, RMG Associates, has over 30 years of experience in the biotechnology and pharmaceutical industries as a consultant on strategy and communications, in-house communications director, and journalist. He also works with government economic development agencies and life science companies in their regions to support their partnering, financing, and other commercial efforts in the U.S. Robert co-founded Feinstein Kean Healthcare (now a division of Ogilvy Public Relations Worldwide), a communications and business consulting firm focused exclusively on biotechnology, pharmaceutical, and related healthcare organizations. Mr. Gottlieb has served as an advisor to the Massachusetts Biotechnology Council for over 15 years. He also participates as a mentor in MIT's Venture Mentoring Service and in the Boston University Business School's Health Sector mentoring program. He also serves as a member of the Board of Directors of the New England Israel Business Council. Previously, Robert directed press relations and corporate communications at Biogen Inc. and was executive editor of F-D-C Reports, "The Pink Sheet," During his ten-years at "The Pink Sheet," he covered the FDA and drug regulation, pharmaceutical business, and the emergence of biotechnology as an industry. Robert holds a B.A. degree from Trinity College (Connecticut).